Imidazoline I2 Receptor Inhibitor Idazoxan Regulates the Progression of Hepatic Fibrosis via Akt-Nrf2-Smad2/3 Signaling Pathway
Oncotarget- United States
doi 10.18632/oncotarget.15472
Full Text
Abstract
Available in
Categories
Date
February 18, 2017
Authors
Publisher
Impact Journals, LLC